Photo of Yakup Ergün from obdh.com.tr
Oct 12, 2024, 00:25
Yakup Ergün: A drug that neither prolongs life nor improves quality of life is not considered successful
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X:
” Each paragraph can be addressed with counterarguments individually. However, collectively, I would say the following: I do not agree with the authors’ views.
A drug that neither prolongs life nor improves quality of life is not considered successful. If the confirmatory trial yields negative results, the accelerated approval should be withdrawn.”
Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug
Authors: Gautam U. Mehta and Richard Pazdur.
Source: Yakup Ergün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43